Drug Discovery World
MAY 1, 2024
DDW’s Megan Thomas speaks to industry experts and thought leaders about the potential for therapeutic antibodies in 2024. Artificial intelligence (AI) AI is on everyone’s minds as we head into 2024; of course, this is across not just the drug discovery spectrum but is particularly relevant to therapeutic antibodies.
Drug Discovery World
MAY 6, 2024
In 2023, large pharmaceutical company Servier opened its Research and Development Institute in the cross-disciplinary innovation hub at Paris-Saclay, which it hopes will be home to nearly 25% of all scientific research activities in France. So, in this way there is a cross fertilisation from the bigger companies to newer ones.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Vial
MARCH 1, 2024
from 2024 to reach US$129.8 Recent advancements In February 2024, PPD announced the addition of mycoplasma and biosafety testing capabilities to its good manufacturing practices (GMP) lab in Wisconsin, US. As a result, the global CRO market is estimated to grow at a compound annual growth rate (CAGR) of 9.6% billion by 2029.
Elrig
APRIL 29, 2024
Joining Isomorphic Labs in October 2024, I’m thrilled to be part of their mission to revolutionize DD through AI/ML. Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease.
Codon
FEBRUARY 13, 2024
” A Global View Even as advances in computing and molecular biology usher in the era of a new, high-tech “phage therapy 2.0”, He is editor of The Biologist , a magazine published by the Royal Society of Biology, and author of The Good Virus: The Amazing Story and Forgotten Promise of the Phage.
Expert insights. Personalized for you.
147 
Let's personalize your content